bioecon 会员专区
供应商 · 研究机构 · 工业生物技术与生物基材料

Turion Labs

AION Labs 是一家风险工作室(venture studio),专注创建并投资以 AI 变革药物发现与开发的初创公司:由阿斯利康、默克、辉瑞、梯瓦(Teva)、Israel Biotech Fund、Amiti Ventures 和 AWS 组成的独特伙伴关系。AION Labs 把深厚的制药研发专长与尖端 AI 相结合,创建降险且契合行业方向的创投企业;通过共同开发模式,初创公司可早期获得制药洞察、研发推动者和真实世界验证机会,以及结构化的公司构建支持与资金。三年间,AION Labs 已孵化九家公司,交付多个跨药物研发的制药试点与合作,并通过后续融资、估值上调轮和一次战略并购获得强有力的市场验证。

运营中 新加坡亚洲 成立 2025 核实于 2026-10-05

简介

Turion Labs is a Singapore-headquartered biotech innovation platform that provides shared laboratory infrastructure, contract research organization (CRO) services, and regulatory navigation to help early-stage life science and food-tech companies scale in Southeast Asia. Incorporated in June 2025, the company operates as a joint venture between South Korea’s S&S LAB and Indonesia’s Future Lestari.

The company maintains a headquarters in Singapore and a flagship facility at the BSD Biomedical Campus in Indonesia. It is currently active with an estimated staff of 1 to 10 employees. While no formal venture capital funding rounds have been disclosed, the company is backed by its founding partners and maintains strategic industry connections. Expansion plans include additional sites in Thailand, Malaysia, and the Philippines.

Sources#

行业
工业化学
主题
合成生物学平台与生物制造
角色
研究机构 — “…ry infrastructure, contract research organization (CRO) services, and regulatory navigation to help early-stag…”

供应的生物解决方案 0

尚未被列为已评级方案的供应商。

产品与服务

该公司未公开其产品或服务——我们可通过引荐了解。

新闻与状态 6

关系网络:股东、合作伙伴、同类

股权与投资方 3

母公司Joint venture / backed by S&S LAB
投资方S&S LAB
投资方Future Lestari

合作与交易 1

合资企业Southeast Asia
…h companies scale in Southeast Asia. Incorporated in June 2025, the company operates as a joint venture between South Korea’s S&S LAB and Indonesia’s Future Lestari. The company maintains a he…

同类企业

Pharmaron · WuXi Biologics · BiBo Biopharma Engineering Co.,Ltd. · Aragen Life Sciences · WuXi XDC · TCG Lifesciences Pvt Ltd. · Sinopep Jiangsu Inc. · ESCO ASTER PTE LTD

身份与联系方式

联系方式、人员和法律信息仅向会员开放。

会员登录